Quantitative EEG, SPEM, and psychometric studies in schizophrenics before and during differential neuroleptic therapy.
D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D001288:Attention / Q000187:drug effects; D001921:Brain / Q000187:drug effects*; D003984:Dibenzazepines / Q000627:therapeutic use; D004569:Electroencephalography; D005133:Eye Movements / Q000187:drug effects*; D006220:Haloperidol / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008568:Memory / Q000187:drug effects; D011352:Procyclidine / Q000627:therapeutic use; D011597:Psychomotor Performance / Q000187:drug effects*; D011930:Reaction Time / Q000187:drug effects; D012559:Schizophrenia / Q000188:drug therapy*
D014150:Antipsychotic Agents; D003984:Dibenzazepines; D011352:Procyclidine; C041528:fluperlapine; D006220:Haloperidol